World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 13 January 2015
Main ID:  ISRCTN19338940
Date of registration: 20/12/2005
Prospective Registration: No
Primary sponsor: Bury Primary Care Trust (UK)
Public title: Can we introduce evidence based prescribing of complementary drug therapies into primary care? A randomised controlled trial.
Scientific title:
Date of first enrolment: 26/06/2004
Target sample size: 55
Recruitment status: Completed
URL:  http://isrctn.com/ISRCTN19338940
Study type:  Interventional
Study design:  Cluster randomised controlled trial (Treatment)  
Phase: 
Countries of recruitment
United Kingdom
Contacts
Name: Maria Paola    Dey
Address:  Department of Public Health Bury Primary Care Trust 21 Silver Street BL9 0EN Bury United Kingdom
Telephone:
Email: MPDey@uclan.ac.uk
Affiliation: 
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: General practitioners in Bury PCT
Exclusion criteria: General practitioners on the local medicines management subgroup and the other GPs in their practices

Age minimum:
Age maximum:
Gender: Both
Health Condition(s) or Problem(s) studied
Osteoarthritis
Musculoskeletal Diseases
Gonarthrosis
Intervention(s)
Dissemination of a recommendation for the prescribing of glucosamine for knee osteoarthritis endosed by the Bury PCT Medicines Management Subgroup and accompanied by a letter of support signed by the Director of Public Health, Bury PCT.
Primary Outcome(s)
Change in the mean number of prescriptions for glucosamine sulphate 500 mg per general practitioner over study period.
Secondary Outcome(s)
1. Change in cost to the NHS of prescriptions for glucosamine per general practitioner over study period
2. Proportion of GP prescribing glucosamine sulphate 500 mg during study period
3. If sufficient change in prescribing observed, number of admissions for gastrointestinal bleeding
4. Change in mean number of prescriptions of NSAID and COX2
Secondary ID(s)
N/A
Source(s) of Monetary Support
Bury Primary Care Trust (UK)
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history